Connection
Linda Barbour to Metformin
This is a "connection" page, showing publications Linda Barbour has written about Metformin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.597 |
|
|
|
-
Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, Aagaard K, Thornburg KL, Catalano PM, Galan HL, Hay WW, Frias AE, Shankar K, Simmons RA, Moses RG, Sacks DA, Loeken MR. A cautionary response to SMFM statement: pharmacological?treatment of gestational diabetes. Am J Obstet Gynecol. 2018 10; 219(4):367.e1-367.e7.
Score: 0.477
-
Barbour LA, Davies JK. Comment on Nachum et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care 2017;40:332-337. Diabetes Care. 2017 08; 40(8):e115.
Score: 0.448
-
Barbour LA. Unresolved controversies in gestational diabetes: implications on maternal and infant health. Curr Opin Endocrinol Diabetes Obes. 2014 Aug; 21(4):264-70.
Score: 0.364
-
Barbour LA, Van Pelt RE, Brumbaugh DE, Hernandez TL, Friedman JE. Comment on: Rowan et al. Metformin in Gestational diabetes: The Offspring Follow-Up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011;34:2279-2284. Diabetes Care. 2012 Mar; 35(3):e28; author reply e30.
Score: 0.308